HCPCS Level IIdrugActive
J7189
Factor viia recomb novoseven
BETOS: O1E
Effective: 2021-01-01
Referenced in 5 policies
Description
Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Novoseven RT
Manufacturer
Novo Nordisk, Inc
HCPCS Dosage
1 MCG
Billing Units
1000.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.